Volume 18, Issue 2 pp. 207-211
Original Article

Assessment of melanocytic skin lesions with a high-definition laser Doppler imaging system

Robert E. Hunger

Corresponding Author

Robert E. Hunger

Department of Dermatology, University of Berne, Bern, Switzerland

Address:

Robert E. Hunger

Department of Dermatology

University Hospital

Inselspital

3010 Bern

Switzerland

Tel: +41 31 632 2613

Fax: +41 31 632 2233

e-mail: [email protected]

Search for more papers by this author
Rocco Della Torre

Rocco Della Torre

Department of Dermatology, University of Berne, Bern, Switzerland

Search for more papers by this author
Alexandre Serov

Alexandre Serov

Service of Immunology and Allergy, Central University Hospital of Lausanne (CHUV), Switzerland

Search for more papers by this author
Thomas Hunziker

Thomas Hunziker

Department of Dermatology, University of Berne, Bern, Switzerland

Search for more papers by this author
First published: 24 August 2011
Citations: 7

Abstract

Background

Early detection is a major goal in the management of malignant melanoma. Besides clinical assessment many noninvasive technologies such as dermoscopy, digital dermoscopy and in vivo laser scanner microscopy are used as additional methods. Herein we tested a system to assess lesional perfusion as a tool for early melanoma detection.

Methods

Laser Doppler flow (FluxExplorer) and mole analyser (MA) score (FotoFinder) were applied to histologically verified melanocytic nevi (33) and malignant melanomas (12).

Results

Mean perfusion and MA scores were significantly increased in melanoma compared to nevi. However, applying an empirically determined threshold of 16% perfusion increase only 42% of the melanomas fulfilled the criterion of malignancy, whereas with the mole analyzer score 82% of the melanomas fulfilled the criterion of malignancy.

Conclusion

Laser Doppler imaging is a highly sensitive technology to assess skin and skin tumor perfusion in vivo. Although mean perfusion is higher in melanomas compared to nevi the high numbers of false negative results hamper the use of this technology for early melanoma detection.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.